Home › Funds › Arrowstreet Capital › GOSS
Arrowstreet Capital position in GOSS
GOSSAMER BIO INC · Health Care
Latest position (Q2 2026)7.57M sh
Reported value held$1.25M
Portfolio Weight0.00%
First reportedQ1 2022
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2022 | 35.25K | $306.00K | New |
| Q1 2025 | 803.82K | $884.20K | New |
| Q2 2025 | 1.12M | $1.38M | Add |
| Q3 2025 | 635.40K | $1.67M | Reduce |
| Q4 2025 | 750.31K | $2.33M | Add |
| Q2 2026 | 7.57M | $1.25M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding GOSS
- Vanguard Group 12.87M sh · $39.91M · Q4 2025
- D. E. Shaw & Co 40.96M sh · $6.74M · Q2 2026
- AQR Capital Management 15.63M sh · $2.57M · Q2 2026
- Renaissance Technologies 11.63M sh · $1.91M · Q2 2026
- BlackRock Inc 7.67M sh · $1.26M · Q2 2026
- Two Sigma Investments 7.43M sh · $1.22M · Q2 2026
- Hillhouse Capital (HHLR Advisors) 4.97M sh · $818.73K · Q2 2026
- UBS Group AG 3.09M sh · $510.47K · Q2 2026
- Geode Capital Management 2.48M sh · $408.71K · Q2 2026
- Millennium Management 2.40M sh · $395.47K · Q2 2026
- Marshall Wace 2.11M sh · $338.40K · Q2 2026